Ji Lu

1.6k total citations
8 papers, 813 citations indexed

About

Ji Lu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Ji Lu has authored 8 papers receiving a total of 813 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Cancer Research. Recurrent topics in Ji Lu's work include Cancer-related molecular mechanisms research (3 papers), Radiomics and Machine Learning in Medical Imaging (1 paper) and RNA modifications and cancer (1 paper). Ji Lu is often cited by papers focused on Cancer-related molecular mechanisms research (3 papers), Radiomics and Machine Learning in Medical Imaging (1 paper) and RNA modifications and cancer (1 paper). Ji Lu collaborates with scholars based in China and United States. Ji Lu's co-authors include Shancheng Ren, Fubo Wang, Min Wei, Chuanliang Xu, Xu Gao, Yinghao Sun, Jiaoti Huang, Jian Shen, Yi Sun and Weidong Xu and has published in prestigious journals such as The Journal of Urology, European Journal of Cancer and Journal of Molecular Medicine.

In The Last Decade

Ji Lu

8 papers receiving 808 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ji Lu China 6 675 666 131 46 46 8 813
Junqing Hou China 11 280 0.4× 292 0.4× 85 0.6× 58 1.3× 35 0.8× 25 428
You Shuai China 11 442 0.7× 489 0.7× 47 0.4× 59 1.3× 43 0.9× 24 593
Jiang‐Hui Zeng China 14 353 0.5× 360 0.5× 122 0.9× 64 1.4× 46 1.0× 31 505
Longke Ran China 13 231 0.3× 277 0.4× 121 0.9× 49 1.1× 20 0.4× 23 427
Yunong Fu China 12 307 0.5× 358 0.5× 118 0.9× 67 1.5× 34 0.7× 16 479
Fangfeng Liu China 14 386 0.6× 414 0.6× 100 0.8× 86 1.9× 60 1.3× 26 552
Kristina Daniūnaitė Lithuania 13 263 0.4× 347 0.5× 166 1.3× 65 1.4× 41 0.9× 23 506
Xiaoru Xin China 14 473 0.7× 536 0.8× 30 0.2× 53 1.2× 25 0.5× 18 634
Yunpeng Jin China 10 339 0.5× 406 0.6× 32 0.2× 63 1.4× 76 1.7× 29 514
Xiao-Jing Luo China 6 442 0.7× 488 0.7× 78 0.6× 107 2.3× 27 0.6× 8 616

Countries citing papers authored by Ji Lu

Since Specialization
Citations

This map shows the geographic impact of Ji Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ji Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ji Lu more than expected).

Fields of papers citing papers by Ji Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ji Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ji Lu. The network helps show where Ji Lu may publish in the future.

Co-authorship network of co-authors of Ji Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Ji Lu. A scholar is included among the top collaborators of Ji Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ji Lu. Ji Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Liang, Yi, et al.. (2022). Machine Learning-Based Models Enhance the Prediction of Prostate Cancer. Frontiers in Oncology. 12. 19 indexed citations
2.
Lu, Ji, Na Hao, Qin Sun, et al.. (2019). A Polymer Responsive to Reactive Oxygen Species for Safe, Efficient Chemo-Photodynamic Combined Cancer Therapy. Journal of Biomedical Nanotechnology. 15(10). 2045–2058. 5 indexed citations
3.
SUN, Ying-hao, Yi Sun, Min Wei, et al.. (2014). Histone methyltransferase SETDB1 is required for prostate cancer cell proliferation, migration and invasion. Asian Journal of Andrology. 16(2). 319–319. 46 indexed citations
4.
Xu, Chuanliang, Weidong Xu, Shancheng Ren, et al.. (2013). Establishment of a Chinese bladder cancer cell line (T921) with high metastatic activity. In Vitro Cellular & Developmental Biology - Animal. 49(9). 668–678. 2 indexed citations
5.
Ren, Shancheng, Fubo Wang, Jian Shen, et al.. (2013). Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer. European Journal of Cancer. 49(13). 2949–2959. 271 indexed citations
6.
Ren, Shancheng, Yawei Liu, Weidong Xu, et al.. (2013). Long Noncoding RNA MALAT-1 is a New Potential Therapeutic Target for Castration Resistant Prostate Cancer. The Journal of Urology. 190(6). 2278–2287. 259 indexed citations
7.
Cui, Zilian, Shancheng Ren, Ji Lu, et al.. (2012). The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor. Urologic Oncology Seminars and Original Investigations. 31(7). 1117–1123. 167 indexed citations
8.
Ren, Shancheng, Chuanliang Xu, Zilian Cui, et al.. (2012). Oncogenic CUL4A determines the response to thalidomide treatment in prostate cancer. Journal of Molecular Medicine. 90(10). 1121–1132. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026